These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 28475642

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. HLA-E-restricted CD8+ T Lymphocytes Efficiently Control Mycobacterium tuberculosis and HIV-1 Coinfection.
    La Manna MP, Orlando V, Prezzemolo T, Di Carlo P, Cascio A, Delogu G, Poli G, Sullivan LC, Brooks AG, Dieli F, Caccamo N.
    Am J Respir Cell Mol Biol; 2020 Apr; 62(4):430-439. PubMed ID: 31697586
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. HIV Interferes with Mycobacterium tuberculosis Antigen Presentation in Human Dendritic Cells.
    Singh SK, Andersson AM, Ellegård R, Lindestam Arlehamn CS, Sette A, Larsson M, Stendahl O, Blomgran R.
    Am J Pathol; 2016 Dec; 186(12):3083-3093. PubMed ID: 27746182
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection.
    Holderried TA, Lang PA, Kim HJ, Cantor H.
    Proc Natl Acad Sci U S A; 2013 Dec 24; 110(52):21089-94. PubMed ID: 24324159
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cytotoxic T lymphocytes in resistance to tuberculosis.
    Mazzaccaro RJ, Stenger S, Rock KL, Porcelli SA, Brenner MB, Modlin RL, Bloom BR.
    Adv Exp Med Biol; 1998 Dec 24; 452():85-101. PubMed ID: 9889963
    [Abstract] [Full Text] [Related]

  • 31. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
    Axelsson-Robertson R, Weichold F, Sizemore D, Wulf M, Skeiky YA, Sadoff J, Maeurer MJ.
    Immunology; 2010 Apr 24; 129(4):496-505. PubMed ID: 20002212
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment.
    Axelsson-Robertson R, Rao M, Loxton AG, Walzl G, Bates M, Zumla A, Maeurer M.
    Int J Infect Dis; 2015 Mar 24; 32():23-9. PubMed ID: 25809751
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.
    Lewinsohn DA, Winata E, Swarbrick GM, Tanner KE, Cook MS, Null MD, Cansler ME, Sette A, Sidney J, Lewinsohn DM.
    PLoS Pathog; 2007 Sep 21; 3(9):1240-9. PubMed ID: 17892322
    [Abstract] [Full Text] [Related]

  • 38. A novel tuberculosis antigen identified from human tuberculosis granulomas.
    Yu Y, Jin D, Hu S, Zhang Y, Zheng X, Zheng J, Liao M, Chen X, Graner M, Liu H, Jin Q.
    Mol Cell Proteomics; 2015 Apr 21; 14(4):1093-103. PubMed ID: 25605460
    [Abstract] [Full Text] [Related]

  • 39. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.
    Höhn H, Kortsik C, Zehbe I, Hitzler WE, Kayser K, Freitag K, Neukirch C, Andersen P, Doherty TM, Maeurer M.
    Scand J Immunol; 2007 May 21; 65(5):467-78. PubMed ID: 17444958
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.